Earnings History Data for Tonix Pharmaceuticals (TNXP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Tonix Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
09-11-2023 | AH | TNXP | Tonix Pharmaceuticals | 9.00 | -1.83 | -1.49 | 0.00 | Tonix Pharmaceuticals GAAP EPS of -$1.83, revenue of $4M [11/10/2023 11:45 AM] |
0.4689 | 0.0 (-0.23%) |
0.48 | 0.01 (1.28%) |
0.43 - 9.81 | 439,241 | 340,000 | 17,390 | ||
10-08-2023 | AH | TNXP | Tonix Pharmaceuticals | 10.00 | -2.68 | -2.78 | 0.00 | Tonix Pharmaceuticals GAAP EPS of -$2.68 misses by $0.66 [8/10/2023 5:17 PM] |
0.9550 | -0.02 (-2.52%) |
0.94 | -0.04 (-4.04%) |
0.89 - 10.31 | 342,703 | 1,460,000 | 7,848 | ||
07-11-2022 | PM | 7:00 AM ET (Nov 7) |
TNXP | Tonix Pharmaceuticals | 20.00 | -0.69 | -0.72 | 0.00 | Tonix Pharmaceuticals GAAP EPS of -$0.69 beats by $0.33 [11/7/2022 7:32 AM] |
0.4650 | 0.01 (3.31%) |
0.46 | 0.01 (2.18%) |
0.44 - 19.43 | 807,503 | 1,080,000 | 55,239 | |
14-03-2022 | PM | TNXP | Tonix Pharmaceuticals | 111.00 | -0.07 | -0.07 | 0.00 | Tonix Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 [3/14/2022 7:04 AM] |
0.2094 | -0.01 (-6.10%) |
0.22 | 0.0 (0.90%) |
0.15 - 1.59 | 15,625,249 | 25,172,890 | 929,706 | ||
10-05-2021 | AH | TNXP | Tonix Pharmaceuticals Holding Corp. | 359.00 | -0.07 | -0.06 | 0.00 | Tonix Pharmaceuticals EPS misses by $0.01 [5/10/2021 4:59 PM] |
1.03 | 0.01 (0.49%) |
0.96 | -0.07 (-6.80%) |
0.51 - 2.46 | 7,412,935 | 9,540,000 | 501,026 | ||
15-03-2021 | AH | TNXP | Tonix Pharmaceuticals Holding Corp. | 389.00 | -0.10 | -0.09 | 0.00 | Tonix Pharmaceuticals EPS misses by $0.03 [3/15/2021 4:56 PM] |
1.28 | -0.03 (-2.29%) |
1.32 | 0.01 (0.76%) |
0.50 - 2.46 | 13,442,351 | 19,226,738 | 293,846 | ||
|
||||||||||||||||||
10-08-2020 | PM | TNXP | Tonix Pharmaceuticals Holding Corp. | 150.89 | -0.23 | -0.21 | -9.50 | Tonix Pharmaceuticals EPS misses by $0.02 [8/10/2020 8:51 AM] |
1.03 | -0.08 (-7.59%) |
1.10 | -0.02 (-1.79%) |
0.39 - 5.89 | 12,256,779 | 16,839,364 | 372,471 | ||
|